联合检测AFP、CEA和CA199对原发性肝癌的诊断价值

AFPCEACA199,(,,210029):AFPCEACA199,4050AFPCEACA199AFPCEACA199(P0.01)AFPCEACA19967.5%27.5%50%,AFPCEACA19985.0%90.0%,95%,AFP,CA199CEA53.8%23.1%AFPCEACA199AFP:AFP;CEA;CA199;;;:R473173:A:1672O2353(2009)06O0001O02,,,,(AFP),30%40%AFP[1],,,AFP(CEA)199(CA199),,AFP,11.12004120081267075,40,2713,2.08:1,4084,(4819),BCTMRI50,,,3515,2.3:1,(4521),,21.2AFPCEACA199,AFPCEA,E170CA199Beackman,BeackmanDXL800,:AFP013.6g/L,CEA04.3g/L,CA199039kU/L1.33mL,,2h1.4SPSS1.0,AFPCEACA199xs,t,3AFPCEACA199AFP,2AFPCEACA1991:2009-01-15:(1964-),,,200956()JournalofClinicalMedicineinPractice11AFPCEACA199(xs)AFP(g/L)CEA(g/L)CA199(kU/L)40318.98698.7820.6841.62101.41133.88507.3113.72332.402.073319.2222.983333P0.01223(%)AFP67.582.075.6CEA27.586.060.0CA19950.080.067.0AFPCEA85.078.081.0AFPCA19990.0380.084.0AFPCEACA19995.03378.085.5:AFP,3P0.05,33P0.01AFPCEACA199(P0.01),AFP67.5%,CA19950%,CEA27.5%23,,,3(PHC)95%,75.6%85.5%,40PHCAFPCEACA199,AFPCA199CTPHC7,53.8%AFPCEAPHC3,23.1%AFPCEA,CA199PHC4,30.76%,2CT3cm,33.1,,,,,,7:309:30,10:00,,3.2,,,,,,,,,,,,5min,,,,,3.3,,,,,3.4,,,,,,,,,,,1,,3.5[2],,,,,,(4)2()5,,[3O4]:5OFU[5],(),5OFU,,5OFU5min25min(),30min[6],,,,,:,(),,2.3,,,,,,,,,,,[1].[M].:,1990:99.[2],.[J].,2006,20(1c):214.[3],,.5OFU[J].,2005,33(1):98.[4].[J].,2006,13(22):2057.[5].5OFU[J].,2002,18(2):206.[6].[M].:,2007:113.(2)4,,,,2,,[3],[4O5],,,,:3AFPPHC,67.5%AFPCEACA199,AFPCEA85%,AFPCA19990%,95%,AFPPHC,CEACA19923.1%53.8%,,PHC,,,(,,),,,,AFPCEACA199,,AFP[1].[M].2.:,2001:553.[2],.[M].,2003,38(9):707.[3].[J].,2005,28(1):11.[4]MirallesC,OreaM,EspanaP,etal.Cancerantigen125asso2ciatedwithmultiplebenignandmalignantpathologies[J].AnnSurgOncol,2003,10(2):150.[5],.[J].,2007,4(4):271.4()5